b7 pharmacy

6 b7 pharmacy job listings in United States. Find daily updated positions from leading job boards.


  • Boston, Massachusetts, United States Aktis Oncology Full-time $122,850 - $176,000 Contract

    About Aktis OncologyAktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis’ most-advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with...


  • Reno, Nevada, United States Renown Health Full-time

    Pediatric Oncology NP or PA– Area’s Children’s Hospital - Beautiful Reno-Tahoe   Renown Health, the largest not-for-profit healthcare network in northern Nevada, is seeking a Pediatric Oncology Nurse Practitioner or Physician Assistant to join our growing Pediatric Specialty Department. As the only Level II Trauma Center for both adults and children...


  • Brooklyn, New York, United States NHS Full-time

    Lincolnshire Partnership NHS Foundation Trust Specialist Clinical Pharmacist The closing date is 28 September 2026 Are you a clinical pharmacist with a passion for delivering outstanding care that brings the 6 Cs (care, compassion, commitment, courage, communication and competence) to life? If so, we want to hear from you. We are seeking to appoint a highly...


  • Boston, Massachusetts, United States ADP Full-time

    If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.Senior Clinical Trial ManagerSalary Range: $122,850.00 To $176,000.00 AnnuallyAbout Aktis OncologyAktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential...


  • Boston, MA, MA, United States Aktis Oncology Full-time $122,850 - $176,000 Contract

    Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis’ most-advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential...